CN101843705B - Chinese medicament for treating lupus erythematosus - Google Patents

Chinese medicament for treating lupus erythematosus Download PDF

Info

Publication number
CN101843705B
CN101843705B CN2009102355002A CN200910235500A CN101843705B CN 101843705 B CN101843705 B CN 101843705B CN 2009102355002 A CN2009102355002 A CN 2009102355002A CN 200910235500 A CN200910235500 A CN 200910235500A CN 101843705 B CN101843705 B CN 101843705B
Authority
CN
China
Prior art keywords
radix
parts
chinese medicine
chinese
lupus erythematosus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009102355002A
Other languages
Chinese (zh)
Other versions
CN101843705A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009102355002A priority Critical patent/CN101843705B/en
Publication of CN101843705A publication Critical patent/CN101843705A/en
Application granted granted Critical
Publication of CN101843705B publication Critical patent/CN101843705B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a Chinese medicament for treating lupus erythematosus, and belongs to the field of Chinese medicaments for treating dermatosis. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: common clubmoss herb, root of rehmannia, Chinese angelica, cassia twig, processed radix aconiti, lucid ganoderma, radix pseudo-ginseng and the like. The Chinese medicament has the effects of tonifying qi and nourishing blood, activating blood and dissolving stasis, and dispelling wind and removing dampness, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

A kind of Chinese medicine for the treatment of lupus erythematosus
Technical field
The invention belongs to the dermopathic field of Chinese medicines of treatment.
Background technology
At present, be intended to treat the field of Chinese medicines of lupus erythematosus, exist the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that many lupus erythematosus patients can not get the treatment of active drug for a long time, prolonged low grade fever, skin lesion and arthralgia are serious, and usually involve kidney, heart, respiratory system etc., course of disease delay, outbreak repeatedly, patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of lupus erythematosus, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of lupus erythematosus adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Lycopodii 4-30 part Radix Rehmanniae 4-30 part Radix Angelicae Sinensis 4-30 part
Ramulus Cinnamomi 4-30 part Radix Aconiti Preparata 3-25 part Ganoderma 2-15 part
Radix Notoginseng 3-25 part
The Chinese medicine of this treatment lupus erythematosus is made by following method:
(1) by above-mentioned weight ratio, Herba Lycopodii, the Radix Rehmanniae, Radix Angelicae Sinensis, Ramulus Cinnamomi, Radix Aconiti Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating in the side, benefiting QI and nourishing blood, tonification the five internal organs; Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; Be aided with the Ramulus Cinnamomi warming the meridian for promoting the flow of YANG QI, kind the aching and edema, dysuria of anemofrigid-damp arthralgia of controlling; The Herba Lycopodii expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, have bring down a fever, heart tonifying, diuresis; The Radix Aconiti Preparata expelling wind and removing dampness, antalgic, the kind anemofrigid-damp arthralgia, arthralgia controlled.All medicine compatibilities, strengthening vital QI to eliminate pathogenic factors brings out the best in each other, and plays benefiting QI and nourishing blood altogether, blood circulation promoting and blood stasis dispelling, the merit of expelling wind and removing dampness, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Herba Lycopodii 60 gram Radix Rehmanniae 60 gram Radix Angelicae Sinensis 60 grams
Ramulus Cinnamomi 60 is restrained Radix Aconiti 50 kairine sesames 30 grams
Radix Notoginseng 60 grams
Weight in accordance with regulations, with conventional water extraction process Herba Lycopodii, the Radix Rehmanniae, Radix Angelicae Sinensis, Ramulus Cinnamomi, Radix Aconiti Preparata are extracted, make extractum fine powder 87 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 632 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Herba Lycopodii 180 gram Radix Rehmanniae 180 gram Radix Angelicae Sinensis 180 grams
Ramulus Cinnamomi 180 is restrained Radix Aconiti 150 kairine sesames 90 grams
Radix Notoginseng 150 grams
By above-mentioned same method, make 1789 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Herba Lycopodii 300 gram Radix Rehmanniae 300 gram Radix Angelicae Sinensis 300 grams
Ramulus Cinnamomi 300 is restrained Radix Aconiti 250 kairine sesames 150 grams
Radix Notoginseng 250 grams
By above-mentioned same method, make 2982 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
7 parts of 7 parts of Radix Angelicae Sinensis of 7 parts of Radix Rehmanniae of Herba Lycopodii
4 parts of 5 portions of Ganodermas of 7 parts of Radix Aconiti Preparatas of Ramulus Cinnamomi
5 parts of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts of 20 parts of Radix Angelicae Sinensis of 20 parts of Radix Rehmanniae of Herba Lycopodii
10 parts of 16 portions of Ganodermas of 20 parts of Radix Aconiti Preparatas of Ramulus Cinnamomi
16 parts of Radix Notoginseng
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science lupus erythematosus, through 12 routine clinical observations.Selecting the tcm diagnosis lupus erythematosus is standard: prolonged low grade fever; Skin lesion is serious, and the facial and bridge of the nose is butterfly-like distribution erythema; Arthralgia, surrounding tissue swelling; The state of an illness is often involved kidney, heart, respiratory system and digestive system.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 1 example, women's 11 examples do not have other serious disease, and the age is 25 years old-45 years old, 36.2 years old mean age.
Efficacy determination:
1, produce effects: low grade fever disappears, and limbs are strong; Skin lesion is obviously alleviated; Arthralgia alleviates; Kidney, heart, respiratory system and digestive system disease are alleviated.
2, effective: low grade fever, skin lesion, arthralgia are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.12 philtrums of clinical experiment, produce effects 6 people, effective 5 people, invalid 1 people, total effective rate 91.6%.

Claims (1)

1. a Chinese medicine for the treatment of lupus erythematosus is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Lycopodii 4---30 parts in 30 parts of Radix Rehmanniae 4---30 parts of Radix Angelicae Sinensis 4---
Ramulus Cinnamomi 4---15 parts of 30 parts of Radix Aconiti Preparatas 3---25 portions of Ganodermas 2---
Radix Notoginseng 3---25 parts
The Chinese medicine of this treatment lupus erythematosus is made by following method:
(1) by above-mentioned weight ratio, Herba Lycopodii, the Radix Rehmanniae, Radix Angelicae Sinensis, Ramulus Cinnamomi, Radix Aconiti Preparata are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
CN2009102355002A 2009-10-16 2009-10-16 Chinese medicament for treating lupus erythematosus Expired - Fee Related CN101843705B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009102355002A CN101843705B (en) 2009-10-16 2009-10-16 Chinese medicament for treating lupus erythematosus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009102355002A CN101843705B (en) 2009-10-16 2009-10-16 Chinese medicament for treating lupus erythematosus

Publications (2)

Publication Number Publication Date
CN101843705A CN101843705A (en) 2010-09-29
CN101843705B true CN101843705B (en) 2011-07-20

Family

ID=42768641

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009102355002A Expired - Fee Related CN101843705B (en) 2009-10-16 2009-10-16 Chinese medicament for treating lupus erythematosus

Country Status (1)

Country Link
CN (1) CN101843705B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547674A (en) * 2014-12-24 2015-04-29 广东聚智诚科技有限公司 New application of traditional Chinese medicinal composition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088788A (en) * 1992-12-26 1994-07-06 史宝印 A kind of lupus for the treatment of lupus erythematosus is loose and compound method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088788A (en) * 1992-12-26 1994-07-06 史宝印 A kind of lupus for the treatment of lupus erythematosus is loose and compound method

Also Published As

Publication number Publication date
CN101843705A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787B (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843718B (en) Chinese medicament for treating lupus erythematosus
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101843759B (en) Oral Chinese medicament for treating fracture
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101843717B (en) Chinese medicament for treating coronary disease
CN101850018A (en) Chinese medicament for treating cervical spondylosis
CN101843707B (en) Chinese medicament for treating chronic hepatitis
CN101843731B (en) Chinese medicament for treating femoral head necrosis
CN101850017B (en) Chinese medicament for treating asthma
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101843739B (en) Oral Chinese medicament for treating fracture
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus
CN101843777B (en) Chinese medicament for treating liver cirrhosis
CN101843750B (en) Chinese medicament for treating chronic nephritis
CN101843799B (en) Oral Chinese medicament for treating fracture
CN101843729B (en) Chinese medicament for treating cervical spondylosis
CN101850014B (en) Chinese medicament for treating asthma
CN101843716B (en) Chinese medicament for treating femoral head necrosis
CN101843879B (en) Chinese medicament for treating liver cirrhosis
CN101843798B (en) Oral Chinese medicament for treating fracture
CN101843866A (en) Chinese medicament for treating diabetic feet
CN101843749A (en) Chinese medicament for treating femoral head necrosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO.,

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130701

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130701

Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166.

Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110720

Termination date: 20151016

EXPY Termination of patent right or utility model